Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Update entities : Verona pharma plc save search
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 07:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: 3.48%
H: 2.74%
C: -3.58%
pharma year update financial results
Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
Published: 2024-02-15 (Crawled : 07:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: 0.69%
H: 0.17%
C: -4.67%
pharma report year update financial results
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-02 (Crawled : 07:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: 1.54%
H: 6.41%
C: 3.03%
pharma update financial results
Verona Pharma to Report Third Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-10-19 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: -0.52%
H: 3.8%
C: -0.82%
pharma report update financial results
Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023
Published: 2023-10-06 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: -0.33%
H: 2.26%
C: -0.07%
pharma update commercialization
Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-03 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: 0.0%
H: 6.48%
C: -4.57%
pharma update financial results
Verona Pharma to Report Second Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-07-20 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: 0.38%
H: 0.96%
C: 0.52%
pharma report update financial results
Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-09 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: 2.88%
H: 2.18%
C: -0.13%
pharma update financial results
Verona Pharma to Report First Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-04-25 (Crawled : 08:00) - biospace.com/
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: -0.7%
H: 2.41%
C: -1.07%
pharma report update financial results
Verona Pharma Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Published: 2023-03-07 (Crawled : 08:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: -4.19%
H: 1.32%
C: -6.6%
pharma year financial update results
Verona Pharma to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
Published: 2023-02-21 (Crawled : 10:00) - biospace.com/
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: -3.21%
H: 2.79%
C: -1.25%
pharma report year financial update results
Verona Pharma Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-09 (Crawled : 08:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: 0.54%
H: 3.31%
C: -5.0%
pharma financial update results
Verona Pharma to Report Third Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-10-26 (Crawled : 07:00) - biospace.com/
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: -0.71%
H: 6.71%
C: 3.85%
pharma report financial update results
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-09 (Crawled : 08:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: 101.29%
H: 5.0%
C: -28.31%
pharma update results
Verona Pharma to Announce Top-line Data from Phase 3 ENHANCE-2 Trial of Nebulized Ensifentrine for COPDSecond quarter 2022 financial results and corporate update
Published: 2022-08-08 (Crawled : 21:00) - biospace.com/
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: 4.33%
H: 0.14%
C: -0.57%
pharma trial update
Verona Pharma to Report Second Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-07-29 (Crawled : 07:00) - biospace.com/
VRNA | $16.1 -1.83% -1.86% 490K
|
Health Technology
|
| O: -0.36%
H: 1.83%
C: -1.47%
pharma report update results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.